Home > Patiënteninformatie > Maligne hematologie > Myeloïde ziekten > Acute myeloïde leukemie > Hovon 501

Hovon 501

A Randomized, Placebo-Controlled Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2*(* This study is now only for adult patients with newly diagnosed AML – the original study title was not changed) https://hovon.nl/en/trials/ho501-1

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 15-11-2025, 19:16